BIT 3.57% 8.1¢ biotron limited

biotron is a biotech worth watching

  1. 13,013 Posts.
    lightbulb Created with Sketch. 96
    Up 86% today. Admittedly on small volume but it appears that the bottom is well and truly in.

    Folks familiar with this one will be aware that the company is currently trialing its lead compound for the treatment of Hep C and HIV. The phase Ia/IIb trial is due for completion by the end of this year.

    While this company is essentially a one trick pony, success will be reflected in a significant upside of share value. The antiviral ion channel mechanism represents a new approach to antiviral therapy and has potential to a whole host of other viral diseases. This is, essentially, a new platform technology for which BIT holds covering patents.

    A real risk/reward play.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Mkt cap ! $56.85M
Open High Low Value Volume
8.7¢ 8.7¢ 8.1¢ $197.9K 2.367M

Buyers (Bids)

No. Vol. Price($)
1 73170 8.2¢

Sellers (Offers)

Price($) Vol. No.
8.5¢ 226144 2
View Market Depth
Last trade - 15.59pm 30/10/2020 (20 minute delay) ?
-0.003 ( 4.71 %)
Open High Low Volume
8.7¢ 8.7¢ 8.1¢ 338225
Last updated 15.59pm 30/10/2020 (live) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.